Filtros : "Chemical Biology and Drug Design" Removido: "PLANEJAMENTO DE FÁRMACOS" Limpar

Filtros



Limitar por data


  • Fonte: Chemical Biology and Drug Design. Unidade: EACH

    Assuntos: DIABETES MELLITUS, DIABETES MELLITUS, INIBIDORES DE ENZIMAS, MEDICAMENTO

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAULA, Heberth de et al. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy. Chemical Biology and Drug Design, v. No 2024, n. 5, p. 01-15, 2024Tradução . . Disponível em: http://dx.doi.org/10.1111/cbdd.70016. Acesso em: 07 out. 2025.
    • APA

      Paula, H. de, Bolsoni, C. S., Souza, F. F. de, Fonseca, V. da R., Romão, W., Sairre, M. I. de, et al. (2024). Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy. Chemical Biology and Drug Design, No 2024( 5), 01-15. doi:10.1111/cbdd.70016
    • NLM

      Paula H de, Bolsoni CS, Souza FF de, Fonseca V da R, Romão W, Sairre MI de, Honorio KM, Lacerda Jr. V, Morais PAB. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy [Internet]. Chemical Biology and Drug Design. 2024 ; No 2024( 5): 01-15.[citado 2025 out. 07 ] Available from: http://dx.doi.org/10.1111/cbdd.70016
    • Vancouver

      Paula H de, Bolsoni CS, Souza FF de, Fonseca V da R, Romão W, Sairre MI de, Honorio KM, Lacerda Jr. V, Morais PAB. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy [Internet]. Chemical Biology and Drug Design. 2024 ; No 2024( 5): 01-15.[citado 2025 out. 07 ] Available from: http://dx.doi.org/10.1111/cbdd.70016
  • Fonte: Chemical Biology and Drug Design. Unidade: IFSC

    Assuntos: LEISHMANIA, MECANISMOS DE DEFESA, TRYPANOSOMA CRUZI

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LAPIERRE, Thibault Joseph William Jacques Dit et al. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum. Chemical Biology and Drug Design, v. 103, p. e14525-1-e14525-14 + supporting information, 2024Tradução . . Disponível em: https://doi.org/10.1111/cbdd.14525. Acesso em: 07 out. 2025.
    • APA

      Lapierre, T. J. W. J. D., Farago, D. N., Cruz, M. G. F. de M. L., Resende, D. de M., Oliveira, A. C. R. de, Santos, B. R. M. dos, et al. (2024). Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum. Chemical Biology and Drug Design, 103, e14525-1-e14525-14 + supporting information. doi:10.1111/cbdd.14525
    • NLM

      Lapierre TJWJD, Farago DN, Cruz MGF de ML, Resende D de M, Oliveira ACR de, Santos BRM dos, Souza F de O, Duarte SM, Chelucci RC, Andricopulo AD, Ferreira LLG, Pilau EJ, Murta SMF, Rezende Junior C de O. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum [Internet]. Chemical Biology and Drug Design. 2024 ; 103 e14525-1-e14525-14 + supporting information.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.14525
    • Vancouver

      Lapierre TJWJD, Farago DN, Cruz MGF de ML, Resende D de M, Oliveira ACR de, Santos BRM dos, Souza F de O, Duarte SM, Chelucci RC, Andricopulo AD, Ferreira LLG, Pilau EJ, Murta SMF, Rezende Junior C de O. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum [Internet]. Chemical Biology and Drug Design. 2024 ; 103 e14525-1-e14525-14 + supporting information.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.14525
  • Fonte: Chemical Biology and Drug Design. Unidade: IQSC

    Assuntos: BIOQUÍMICA, BIOLOGIA

    PrivadoAcesso à fonteComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELANDER, Roberta e MONTANARI, Carlos Alberto. Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html. Acesso em: 07 out. 2025. , 2023
    • APA

      Melander, R., & Montanari, C. A. (2023). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • NLM

      Melander R, Montanari CA. Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2023 ;[citado 2025 out. 07 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • Vancouver

      Melander R, Montanari CA. Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2023 ;[citado 2025 out. 07 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
  • Fonte: Chemical Biology and Drug Design. Unidade: IQSC

    Assuntos: BIOQUÍMICA, BIOLOGIA

    PrivadoAcesso à fonteComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html. Acesso em: 07 out. 2025. , 2022
    • APA

      Chemical Biology and Drug Design. (2022). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2025 out. 07 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2025 out. 07 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
  • Fonte: Chemical Biology and Drug Design. Unidades: IQ, FCFRP

    Assuntos: FITOQUÍMICA, ANTIPROTOZOÁRIOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TREFZGER, Ozildeia S et al. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G. Chemical Biology and Drug Design, v. 93, n. 3, p. 313-324, 2019Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13417. Acesso em: 07 out. 2025.
    • APA

      Trefzger, O. S., Neves, A. R. das, Barbosa, N. V., Carvalho, D. B., Pereira, I. C., Perdomo, R. T., et al. (2019). Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G. Chemical Biology and Drug Design, 93( 3), 313-324. doi:10.1111/cbdd.13417
    • NLM

      Trefzger OS, Neves AR das, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, Albuquerque S de, Arruda CCP, Baroni ACM. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G [Internet]. Chemical Biology and Drug Design. 2019 ; 93( 3): 313-324.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.13417
    • Vancouver

      Trefzger OS, Neves AR das, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, Albuquerque S de, Arruda CCP, Baroni ACM. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G [Internet]. Chemical Biology and Drug Design. 2019 ; 93( 3): 313-324.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.13417
  • Fonte: Chemical Biology and Drug Design. Unidade: IQSC

    Assuntos: BIOQUÍMICA, BIOLOGIA

    PrivadoComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf. Acesso em: 07 out. 2025. , 2019
    • APA

      Chemical Biology and Drug Design. (2019). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2025 out. 07 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2025 out. 07 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
  • Fonte: Chemical Biology and Drug Design. Unidades: FCF, ICB

    Assuntos: PLASMODIUM FALCIPARUM, PARASITOLOGIA, MALÁRIA, QUIMIOTERAPIA, ENZIMAS PROTEOLITICAS, ATIVAÇÃO ENZIMÁTICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MEISSNER, Kamila Anna et al. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, v. 2018 p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13416. Acesso em: 07 out. 2025.
    • APA

      Meissner, K. A., Kronenberger, T., Maltarollo, V. G., Trossini, G. H. G., & Wrenger, C. (2018). Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, 2018 p. 1-13. doi:10.1111/cbdd.13416
    • NLM

      Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.13416
    • Vancouver

      Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.13416
  • Fonte: Chemical Biology and Drug Design. Unidade: EACH

    Assuntos: DOENÇA DE CHAGAS, QUÍMICA MÉDICA, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARAIVA, Ádria P. B. et al. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, p. 01-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13313. Acesso em: 07 out. 2025.
    • APA

      Saraiva, Á. P. B., Miranda, R. M., Valente, R. P. P., Araújo, J. O., Souza, R. N. B., Costa, C. H. S., et al. (2018). Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, 01-13. doi:10.1111/cbdd.13313
    • NLM

      Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.13313
    • Vancouver

      Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.13313
  • Fonte: Chemical Biology and Drug Design. Unidade: IQSC

    Assuntos: BIOQUÍMICA, BIOLOGIA

    Versão PublicadaComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Disponível em: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf. Acesso em: 07 out. 2025. , 2017
    • APA

      Chemical Biology and Drug Design. (2017). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Recuperado de https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2025 out. 07 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2025 out. 07 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
  • Fonte: Chemical Biology and Drug Design. Unidade: EACH

    Assuntos: PORFIRINAS, QUÍMICA QUÂNTICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BETTANIN, Fernanda et al. Quantum-chemistry descriptors for photosensitizers based on macrocycles. Chemical Biology and Drug Design, v. 89, n. 2, p. 207-220, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12791. Acesso em: 07 out. 2025.
    • APA

      Bettanin, F., Antonio, F. C. T., Honório, K. M., & Homem-de-Mello, P. (2017). Quantum-chemistry descriptors for photosensitizers based on macrocycles. Chemical Biology and Drug Design, 89( 2), 207-220. doi:10.1111/cbdd.12791
    • NLM

      Bettanin F, Antonio FCT, Honório KM, Homem-de-Mello P. Quantum-chemistry descriptors for photosensitizers based on macrocycles [Internet]. Chemical Biology and Drug Design. 2017 ; 89( 2): 207-220.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.12791
    • Vancouver

      Bettanin F, Antonio FCT, Honório KM, Homem-de-Mello P. Quantum-chemistry descriptors for photosensitizers based on macrocycles [Internet]. Chemical Biology and Drug Design. 2017 ; 89( 2): 207-220.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.12791
  • Fonte: Chemical Biology and Drug Design. Unidade: EACH

    Assuntos: RELAÇÕES ESTRUTURA-ATIVIDADE, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, PEPTÍDEOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GUERRA, Mirian Elisa Rodrigues et al. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides. Chemical Biology and Drug Design, p. 1-10, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12970. Acesso em: 07 out. 2025.
    • APA

      Guerra, M. E. R., Fadel, V., Maltarollo, V. G., Baldissera, G., Honório, K. M., Ruggiero, J. R., & Cabrera, M. P. dos S. (2017). MD simulations and multivariate studies for modeling the antileishmanial activity of peptides. Chemical Biology and Drug Design, 1-10. doi:10.1111/cbdd.12970
    • NLM

      Guerra MER, Fadel V, Maltarollo VG, Baldissera G, Honório KM, Ruggiero JR, Cabrera MP dos S. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides [Internet]. Chemical Biology and Drug Design. 2017 ; 1-10.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.12970
    • Vancouver

      Guerra MER, Fadel V, Maltarollo VG, Baldissera G, Honório KM, Ruggiero JR, Cabrera MP dos S. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides [Internet]. Chemical Biology and Drug Design. 2017 ; 1-10.[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/cbdd.12970
  • Fonte: Chemical Biology and Drug Design. Unidade: EACH

    Assuntos: MODELAGEM MOLECULAR, QUÍMICA QUÂNTICA, RECEPTORES

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MALTAROLLO, Vinícius Gonçalves e HONÓRIO, Kathia Maria. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity. Chemical Biology and Drug Design, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1747-0285.2012.01424.x. Acesso em: 07 out. 2025.
    • APA

      Maltarollo, V. G., & Honório, K. M. (2012). Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity. Chemical Biology and Drug Design. doi:10.1111/j.1747-0285.2012.01424.x
    • NLM

      Maltarollo VG, Honório KM. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity [Internet]. Chemical Biology and Drug Design. 2012 ;[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/j.1747-0285.2012.01424.x
    • Vancouver

      Maltarollo VG, Honório KM. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity [Internet]. Chemical Biology and Drug Design. 2012 ;[citado 2025 out. 07 ] Available from: https://doi.org/10.1111/j.1747-0285.2012.01424.x

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025